Disposition of 640 shares by Michael Sousa of HealthStream subject to Rule 16b-3
| TRHCDelisted Stock | USD 8.16 0.62 7.06% |
About 61% of Tabula Rasa's investor base is looking to short. The analysis of current outlook of investing in Tabula Rasa HealthCare suggests that many traders are alarmed regarding Tabula Rasa's prospects. The current market sentiment, together with Tabula Rasa's historical and current headlines, can help investors time the market. In addition, many technical investors use Tabula Rasa HealthCare stock news signals to limit their universe of possible portfolio assets.
Tabula |
Filed transaction by HealthStream Officer: Executive Vice President. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Tabula Rasa Fundamental Analysis
We analyze Tabula Rasa's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tabula Rasa using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tabula Rasa based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Tabula Rasa is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Tabula Rasa HealthCare Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tabula Rasa stock to make a market-neutral strategy. Peer analysis of Tabula Rasa could also be used in its relative valuation, which is a method of valuing Tabula Rasa by comparing valuation metrics with similar companies.
Peers
Tabula Rasa Related Equities
| STRM | Streamline Health | 17.21 | ||||
| DH | Definitive Healthcare | 5.83 | ||||
| NRC | National Research | 2.54 | ||||
| FORA | Forian | 0.49 | ||||
| HSTM | HealthStream | 0.00 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Tabula Stock
If you are still planning to invest in Tabula Rasa HealthCare check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tabula Rasa's history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |